Safety analysis of home-based enzyme replacement therapy with alglucosidase alfa in Pompe disease; a prospective study

被引：0
|
作者：
Ditters, I. [1 ]
van der Ploeg, A. [1 ]
van der Beek, N. [1 ]
van den Hout, J. [1 ]
Huidekoper, H. [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
10.1016/j.nmd.2022.07.146
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
VP.29
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [1] Safety analysis of home-based enzyme replacement therapy with alglucosidase alfa in Pompe disease: A prospective study
    Ditters, Imke A. M.
    van der Ploeg, Ans T.
    van der Beek, Nadine A. M. E.
    van den Hout, Hannerieke . M. P.
    Huidekoper, Hidde H.
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 35 - 36
  • [2] Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective study
    Ditters, Imke A. M.
    van der Beek, Nadine A. M. E.
    Brusse, Esther
    van der Ploeg, Ans T.
    van den Hout, Johanna M. P.
    Huidekoper, Hidde H.
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [3] Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective study
    Imke A. M. Ditters
    Nadine A. M. E. van der Beek
    Esther Brusse
    Ans T. van der Ploeg
    Johanna M. P. van den Hout
    Hidde H. Huidekoper
    Orphanet Journal of Rare Diseases, 18
  • [4] Long-term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: Prospective analysis from the French Pompe Registry
    Semplicini, Claudio
    De Antonio, Marie
    Taouagh, Nadjib
    Bhin, Anthony
    Bouhour, FranOoise
    Echaniz-Laguna, Andoni
    Magot, Armelle
    Nadaj-Pakleza, Aleksandra
    Orlikowski, David
    Sacconi, Sabrina
    Salort-Campana, Emmanuelle
    Sole, Guilhem
    Tard, Cline
    Zagnoli, Fabien
    Hogrel, Jean-Yves
    Hamroun, Dalil
    Lafort, Pascal
    JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (06) : 1219 - 1231
  • [5] Enzyme replacement therapy with alglucosidase alfa in Pompe disease: Clinical experience with rate escalation
    Desai, Ankit K.
    Walters, Crista K.
    Cope, Heidi L.
    Kazi, Zoheb B.
    DeArmey, Stephanie M.
    Kishnani, Priya S.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : 92 - 96
  • [6] Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease
    Tim A. Kanters
    Ans T. van der Ploeg
    Michelle E. Kruijshaar
    Dimitris Rizopoulos
    W. Ken Redekop
    Maureen P. M. H. Rutten-van Mӧlken
    Leona Hakkaart-van Roijen
    Orphanet Journal of Rare Diseases, 12
  • [7] Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantileonset Pompe disease: A systematic review and metanalysis
    Dornelles, Alicia D.
    Schwartz, Ida Vanessa D.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [8] Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in adult patients with Pompe disease
    Kanters, Tim A.
    van der Ploeg, Ans T.
    Kruijshaar, Michelle E.
    Rizopoulos, Dimitris
    Redekop, W. Ken
    Rutten-van Molken, Maureen P. M. H.
    Hakkaart-van Roijen, Leona
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [9] Enzyme replacement therapy with alglucosidase alfa in a late-onset Pompe disease patient during pregnancy
    Santos, Miguel Oliveira
    Evangelista, Teresinha
    Conceicao, Isabel
    NEUROMUSCULAR DISORDERS, 2018, 28 (11) : 965 - 968
  • [10] Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantile-onset Pompe disease: a systematic review and metanalysis
    Dornelles, A. D.
    Junges, A. P. P.
    Krug, B.
    Goncalves, C.
    de Oliveira Junior, H. A.
    Schwartz, I. V. D.
    FRONTIERS IN PEDIATRICS, 2024, 12
12345